Search results
Results From The WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The top 5 best selling pharmaceuticals 2015–2019. Sales in billion USD. [1] Rank ... Eli Lilly and Company, Chugai Pharmaceutical: Osteoporosis: Dec-1997: Jan-2013 ...
Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and vaccines from France's ...
Beyond that, the pharmaceutical company has a robust pipeline. Its weight loss candidates, including retatrutide, look promising. Its weight loss candidates, including retatrutide, look promising.
At today's share price, Pfizer is giving investors a whopping 5.75% dividend yield, higher than virtually any point in the company's history outside of the financial crisis in 2008-2009: PFE ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
This quarterly performance by the weight loss portfolio prompted Lilly to boost the company's full-year revenue guidance by $3 billion to the range of $45.4 billion to $46.6 billion.